Navigation Links
Super Fruit Fly may Harbor Hope for Human Longevity

Researchers at USC and Caltech have spectacularly slowed aging in fruit flies with a new technique that shows general promise in pharmaceutical development .

In a triumph for pests, scientists have found out how to make the fruit fly live longer.

But the development may still have something for humans. As reported online in Nature Chemical Biology, the discovery that a single protein can slow down aging holds implications for humans prolonged existence and for treatment of some of the worlds most dreaded diseases.

This work is important for two reasons, said study author Richard Roberts, associate professor of chemistry, chemical engineering and biology at the University of Southern California.

First, it demonstrates that a single inhibitor can dramatically alter lifespan, a very complex trait. It is remarkable that you can alter it with a single genetic change.

We dont really need to make fruit flies live longer, but if we understand how to do this, our approach may have direct application to higher organisms, such as ourselves, he added.

Secondly, Roberts said, the method used by his research team to make the inhibiting proteins opens the prospect of developing a lot of new therapeutics.

The study describes a new method for blocking receptors involved in aging and disease across many species, including humans.

Receptors are proteins that send out signals across a cell membrane. In the fruit fly, Roberts and his team manufactured short proteins that blocked a receptor involved in fruit fly aging, as earlier demonstrated by co-author Seymour Benzer of Caltech.

The results were spectacular. Flies with a blocked receptor saw their lives extended by a third, with no noticeable side effects.

The same blocking strategy should work in all such receptors, known as class B GPCRs (for G protein-coupled receptors). Many GPCRs figure promi nently in disease as well as in normal development, Roberts said.

It is the most targeted family of receptors by drug manufacturers, Roberts said, estimating that a quarter of all pharmaceuticals focus on GPCRs.

This approach should be generally applicable, he added.

And generally powerful, given that GPCRs are extremely unstable and difficult to work with. The Roberts group went around the problem by disconnecting the unstable part of the receptor and running experiments only on the part of the receptor that sticks out of the cell.

Though there were no guarantees that inhibiting one part of the receptor would harm the whole, the strategy succeeded.

Roberts method builds on his co-discovery, in 1997, of a simple method for building libraries of trillions of short proteins, or peptides.

In the new study, Roberts and his group literally threw trillions of peptides at the receptor and saved the ones that stuck.

We let the molecules themselves decide if they bind, rather than trying to design them rationally, he said.

After multiple cycles, the researchers had a group of peptides that fixed to the receptor and not to any other protein.

Fruit flies genetically transformed to produce such peptides lived longer, suggesting that the peptides were interfering with the receptors normal function.

However the questions that have been left unanswered are why these particular peptides work, and why the receptor they target plays such an important role in fruit fly aging.




'"/>




Related medicine news :

1. Top Ten Super Food Items That Can Help In Avoiding Cancer
2. Top Ten Super Food Items That Can Help In Avoiding Cancer
3. Super Bugs Contaminate UK Chickens
4. Atypical Antibiotics For Super Bugs
5. Supercomputer Grid Enlists PCs To Combat AIDS
6. Amitabh Bachchan - India’s Superstar Undergoes Surgery
7. “Super Broccoli” Could Confer Better Cancer Protectin
8. Newer Generation Sleeping Pills Lack Superior Performance
9. The MRSA Superbug May Yet Be Overcome
10. Superbug Claims More Lives In Scotland
11. Little Clinic LLC Plans Super Medical Clinics in Publix Super Markets
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer ... East-coast edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes ... 40 speakers — representing such thought-leading companies as JP Morgan Chase, GE ...
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy ... industry-leading compliance software, The Guard®, has helped another long-time client pass their Department ... and properly satisfy the law. , Thanks to the help of the Compliancy ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... campaign, “Humans With Vaginas.” The goal is to ignite conversation via social media ... care products. The brand has declared September “Humans with Vaginas” month, releasing a ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... millions of older Americans at risk of price gouging for their prescription drugs, ... League (TSCL) . “Because Medicare isn’t negotiating on our behalf, there’s no consistency ...
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take on one ... better one’s life through God. “The Trials I Face to Receive God’s Grace” is ... found a love for writing. Green feels that expressing his feelings through prayer will ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017   BioLife Solutions , Inc. (NASDAQ: ... clinical grade cell and tissue hypothermic storage and ... Rice , President and CEO, will be presenting at two ... & Renshaw 19 th Annual Global Investment Conference on ... Pacific time). The conference is being held at the New ...
(Date:9/6/2017)... , Sept. 6, 2017  Medical professionals ... and skills while treating their patients. Medical ... experience without involving patients. Simulation provides a ... can carry out procedures, refine techniques and ... Integration of new technology, such as augmented ...
(Date:9/6/2017)... -- NeuroRx, a clinical stage biopharma company developing the first ... been granted Fast Track status by the US Food and ... followed by NRX-101 (D-cycloserine + lurasidone). The company will shortly ... therapy targeting patients who are admitted to Emergency Departments with ... ...
Breaking Medicine Technology: